Diabetes mellitus, a name that reverberates through the halls of clinics and hospitals worldwide, has become a common household term, having entrenched itself deeply into our daily dialogues. With global prevalence burgeoning, it remains one of the leading public health concerns. In the vast realm of medicine, few areas have evolved as radically as our understanding of diabetes mellitus.
Type 2 diabetes mellitus
Vitamin D and estradiol help guard against heart disease, stroke, and diabetes in postmenopausal women
Vitamin D and estrogen have already shown well-documented results in improving bone health in women. A new study from China suggests that this same combination
Bariatric surgery better for obese with type 2 diabetes
Study compares sleeve gastrectomy with medical treatment in obese patients with type 2 diabetes – A study comparing a bariatric surgical procedure with conventional medical treatment in morbidly obese patients with type 2 diabetes mellitus suggests that surgery was associated with remission or improvement in diabetes-related outcomes.
Low calorie diet improves heart function in diabetic obese patients
Restricted calorie diet improves heart function in obese patients with diabetes – A low-calorie diet eliminates insulin dependence and leads to improved heart function in obese patients with type 2 diabetes. It is striking to see how a relatively simple intervention of a very low calorie diet effectively cures type 2 diabetes mellitus. Moreover, these effects are long term.
Avandia use is restricted for diabetes patients
FDA significantly restricts access to the diabetes drug Avandia — Makes regulatory decisions on RECORD and TIDE trials – FDA will restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. Avandia may elevate risk of cardiovascular events, such as heart attack and stroke.
FDA reviewing Avandia, rosiglitazone and cardiovascular safety
FDA Drug Safety Communication: Ongoing review of Avandia (rosiglitazone) and cardiovascular safety – The U.S. Food and Drug Administration (FDA) is reviewing data, submitted in August 2009, from a large, long-term clinical study on possible risks with the diabetes drug, Avandia (rosiglitazone).
Childhood metabolic measurements may predict diabetes development years later
Childhood metabolic measurements may predict diabetes development years later – A child’s blood pressure, body mass index, blood glucose level and other laboratory tests and simple office measures may predict the risk of developing type 2 diabetes nine and 26 years later.
Check your Levemir insulin XZF0036, XZF0037, XZF0038
Novo Nordisk Warns Customers About Stolen Insulin — FDA Issues Public Health Advisory Regarding Levemir Insulin. – Novo Nordisk product previously reported as stolen in North Carolina has resurfaced recently at a medical center in Houston.
Diabetes early signs in kids as young as 7
LSUHSC researchers first to document early signs for diabetes in kids as young as 7 – Research conducted under the direction of Melinda Sothern, PhD, Professor and Director of Health Promotion at the LSU Health Sciences Center New Orleans School of Public Health, showing early signs of diabetes in healthy children as young as seven years old will be presented at the American Diabetes Association 2009 Annual Scientific Session Meeting in New Orleans.
Dementia risk rises in elderly diabetics after hypoglycemia
Low Blood Sugar Events Increase Dementia Risk in Elderly Patients with Type 2 Diabetes, Kaiser Permanente Study Finds. – Hypoglycemic (low blood sugar) episodes that require a visit to the hospital are associated with increased risk of dementia in elderly patients with type 2 diabetes mellitus.